Found 35 matching trials
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
PHASE1The primary objectives of this study are to investigate the safety and seru...
Location
GH Research Clinical Trial Site
Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)
PHASE2The primary objective of Part 1 of this study is to evaluate the effects of...
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
PHASE1The primary objective of the study is to assess the pharmacokinetics, safet...
Location
Altasciences Clinical Kansas, Inc
Safety and Tolerability of DMT in Healthy Adults
PHASE1This study aims to evaluate the acute and subacute effects of an inhaled N,...
Location
Hospital Universitário Onofre Lopes
Single Ascending Dose Study With BPL-003 in Healthy Subjects
PHASE1The study will evaluate safety, tolerability and PK profile of BPL-003 in h...
Location
Hammersmith Medicines Research
Molecular Imaging Study of Harmine/DMT: a Basic Research Approach
PHASE1The few reports on effects of psychedelic substances on cerebral metabolic ...
Location
Department of Nuclear Medicine, Bern University Hospital
Mindfulness and Psychedelics
EARLY_PHASE1The investigators are doing this project to investigate potential neurophys...
Location
Psychiatric University Hospital Zurich
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
PHASE1Participation in this study lasts approximately two weeks and includes thre...
Location
University Hospital Basel
Effects of Dimethyltryptamine in Healthy Subjects
PHASE1N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance...
Location
University Hospital Basel
Pharmacokinetics of GH001 in Healthy Volunteers
PHASE1The primary objective of this study is to investigate the serum pharmacokin...
Location
GH Research Clinical Trial Site